HealthcareNew finance chief at Aegerion PharmaJun. 25, 2015 8:53 AM ETNovelion Therapeutics Inc. (NVLNF) StockNVLNFBy: Douglas W. House, SA News EditorAegerion Pharmaceuticals (AEGR) appoints Gregory Perry as Chief Financial Officer effective July 6. Interim CFO David Aubuchon will continue his role as Chief Accounting Officer. Previously, Mr. Perry was CFO at Eleven Biotherapeutics.Recommended For YouMore Trending NewsSee More »Related StocksSymbolLast Price% ChgNVLNF--Novelion Therapeutics Inc.Trending AnalysisTrending News